Form 8-K - Current report:
SEC Accession No. 0001437749-24-000113
Filing Date
2024-01-02
Accepted
2024-01-02 09:20:23
Documents
14
Period of Report
2024-01-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K plse20231231_8k.htm   iXBRL 8-K 24233
2 PRESS RELEASE ISSUED BY PULSE BIOSCIENCES, INC. DATED JANUARY 2, 2024 ex_611054.htm EX-99.1 13420
  Complete submission text file 0001437749-24-000113.txt   174148

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plse-20240102.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plse-20240102_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE plse-20240102_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plse-20240102_pre.xml EX-101.PRE 11585
8 EXTRACTED XBRL INSTANCE DOCUMENT plse20231231_8k_htm.xml XML 2555
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 24500577
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)